Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| GZD856 | C29H27F3N6O | 1257628-64-0 | Details |
| H-89 | C20H20BrN3O2S | 127243-85-0 | Details |
| Gosogliptin；PF-00734200;PF-734200 | C17H24F2N6O | 869490-23-3 | Details |
| GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
| GPR120 modulator 1 | C19H16ClNO4S | 1050506-75-6 | Details |
| GPR120 modulator 2 | C20H18ClNO3S | 1050506-87-0 | Details |
| GPI-1046 | C20H28N2O4 | 186452-09-5 | Details |
| Golotimod | C16H19N3O5 | 229305-39-9 | Details |
| Lidocaine Hydrochloride hydrate | C14H25ClN2O2 | 6108-05-0 | Details |
| Diminazene Aceturate | C22H29N9O6 | 908-54-3 | Details |
| GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
| GSK-J2 | C22H23N5O2 | 1394854-52-4 | Details |
| GSK2239633A | C24H25ClN4O5S2 | 1240516-71-5 | Details |
| Menbutone | C15H14O4 | 3562-99-0 | Details |
| GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
| GPR40 Activator 1 | C31H31NO3S | 1309435-60-6 | Details |
| GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
| GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
| GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
| GSK-843 | C19H15N5S2 | 1601496-05-2 | Details |
| GSK-3β inhibitor 2 | C14H14N4O3S | 1702428-31-6 | Details |
| Chlorhexidine dihydrochloride；Chlorhexidine 2HCl;NSC-185;Chlorhexidine hydrochloride | C22H32Cl4N10 | 3697-42-5 | Details |
| GSK-3484862 | C19H19N5OS | 2170136-65-7 | Details |
| GSK 366 | C17H16ClN3O4 | 1953157-39-5 | Details |
| GSK 525768A | C22H22ClN5O2 | 1260530-25-3 | Details |
| GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
| GSK256066 Trifluoroacetate；GSK 256066 Trifluoroacetate;GSK256066 (2,2,2-trifluoroacetic acid) | C29H27F3N4O7S | 1415560-64-3 | Details |
| GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
| GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
| GSK205 | C24H25BrN4S | 1263068-83-2 | Details |
| GSK-5498A | C18H11F6N3O | 1253186-49-0 | Details |
| Molibresib besylate；GSK 525762C;I-BET 762 besylate | C28H28ClN5O5S | 1895049-20-3 | Details |
| GSK-3 inhibitor 1 | C22H17ClFN5O2 | 603272-51-1 | Details |
| GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
| GSK2245035 | C20H34N6O2 | 1207629-49-9 | Details |
| GR 103691 | C30H35N3O3 | 162408-66-4 | Details |
| GRL0617 | C20H20N2O | 1093070-16-6 | Details |
| NE 52-QQ57 | C24H28N6O | 1401728-56-0 | Details |
| GSK-2793660 | C20H27N3O3 | 1613458-70-0 | Details |
| GPR84 antagonist 8 | C23H23N3O5 | 1445846-30-9 | Details |
| GPR4 antagonist 1 | C27H37N5 | 1197879-16-5 | Details |
| Nifedipine；Procardia XL;Procardia;BAY-a-1040;Adalat | C17H18N2O6 | 21829-25-4 | Details |
| Lenacapavir | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| Guancydine；Guancidine | C7H14N4 | 1113-10-6 | Details |
| Camicinal；GSK962040 | C25H33FN4O | 923565-21-3 | Details |
| Camicinal hydrochloride；GSK962040 hydrochloride | C25H34ClFN4O | 923565-22-4 | Details |
| Guanfu base H；Atisinium chloride | C22H34ClNO2 | 4758-99-0 | Details |
| Roxithromycin | C41H76N2O15 | 80214-83-1 | Details |
| GSK2850163 | C24H29Cl2N3O | 2121989-91-9 | Details |
| Guaiapate | C18H29NO4 | 852-42-6 | Details |
| GSTO-IN-2 | C33H52N2O9 | 1202710-57-3 | Details |
| Fenofibrate | C20H21ClO4 | 49562-28-9 | Details |
| GSK2983559 free acid | C21H23N4O7PS2 | 1579965-12-0 | Details |
| GSK3368715 dihydrochloride | C20H39ClN4O2 | 1628925-77-8 | Details |
| Fiboflapon；AM-803;GSK2190915 | C38H43N3O4S | 936350-00-4 | Details |
| Fiboflapon sodium；GSK2190915 sodium salt;AM-803 sodium | C38H44N3NaO4S | 1196070-26-4 | Details |
| GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
| GSK2945 | C20H18Cl2N2O2S | 1438071-12-5 | Details |
| GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
| GSK3532795；BMS-955176 | C42H62N2O4S | 1392312-45-6 | Details |
| GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
| GSK 4027 | C17H21BrN4O | 2079896-25-4 | Details |
| GSK598809 | C22H23F4N5OS | 863680-45-9 | Details |
| GSK726701A | C24H22FNO5 | 945721-87-9 | Details |
| GSK682753A | C23H21Cl3N2O3 | 1334294-76-6 | Details |
| Epelsiban；GSK 557296 | C30H38N4O4 | 872599-83-2 | Details |
| GSK840；GSK'840 | C21H23N3O3 | 2361146-30-5 | Details |
| GSK3368715；EPZ019997 | C20H38N4O2 | 1629013-22-4 | Details |
| GSTO1-IN-1 | C10H12Cl2N2O3S | 568544-03-6 | Details |
| GSK2807 Trifluoroacetate | C21H33F3N8O7 | 2245255-66-5 | Details |
| GSK2593074A | C27H23N5OS | 1337531-06-2 | Details |
| Glyoxalase I inhibitor | C21H30BrClN4O8S | 221174-33-0 | Details |
| GlyRS-IN-1 | C12H17N7O7S | 112921-11-6 | Details |
| GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
| Albendazole | C12H15N3O2S | 54965-21-8 | Details |
| Guanfu base I；Acorine | C22H29NO5 | 110225-59-7 | Details |
| Gum arabic；Arabic gum | N/A | 9000-01-5 | Details |
| GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
| GW806742X | C25H22F3N7O4S | 579515-63-2 | Details |
| GNE-8505 | C21H24F3N5O | 1620573-48-9 | Details |
| GW 766994；GW 994 | C21H24Cl2N4O3 | 408303-43-5 | Details |
| GW274150 | C8H17N3O2S | 210354-22-6 | Details |
| GV-196771A | C20H15Cl2N2NaO3 | 166974-23-8 | Details |
| GNF179 (Metabolite)；GNF179 Metabolite | C14H16FN3 | 1310455-86-7 | Details |
| GNF-6231 | C24H25FN6O2 | 1243245-18-2 | Details |
| GNE 220 | C25H26N8 | 1199590-75-4 | Details |
| GNF362 | C22H21F3N6 | 1003019-41-7 | Details |
| Lidocaine hydrochloride | C14H23ClN2O | 73-78-9 | Details |
| Guanoxabenz；Hydroxyguanabenz | C8H8Cl2N4O | 24047-25-4 | Details |
| GV-58 | C18H26N6OS | 1402821-41-3 | Details |
| GNA002 | C42H55NO8 | 1385035-79-9 | Details |
| Ganfeborole HCl | C10H14BCl2NO4 | 2131798-13-3 | Details |
| GNF4877 | C25H27FN6O4 | 2041073-22-5 | Details |
| GW274150 phosphate | C8H20N3O6PS | 438542-15-5 | Details |
| GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
| GNE-0439 | C21H31NO3 | 1241902-40-8 | Details |
| Guanosine-5'-triphosphate disodium salt | C10H17N5NaO14P3 | 56001-37-7 | Details |
| Gusperimus trihydrochloride；BMS181173;NKT-01;Spanidin | C17H37N7O3.3ClH | 85468-01-5 | Details |
| GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
| GOAT-IN-1 | C18H13ClF3NO3S | 1452473-54-9 | Details |
| Product Total： Product Page： | ||||
| 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 | ||||